Boston pays top dollar for stent leader Schneider
This article was originally published in Clinica
Executive Summary
Boston Scientific last week cemented its position in the booming $1.6 billion stent market after agreeing to pay $2.1 billion in cash for Swiss-based Pfizer's catheter manufacturer, Schneider Worldwide.